Latest Period
Q2 2026
Security Snapshot
UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD) Institutional Ownership
CUSIP: 917488108
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
113
Shares (Excl. Options)
2,317,747
Price
$68.98
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- UTMD on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 2,317,747
- Total 13F value
- $159,887,229
- Portfolio coverage rank
- 0%
- Share change
- +52,811
- Value change
- +$3,832,306
- Number of holders
- 113
- Shares outstanding
- 3,188,980
- SEC-reported price per share
- $69.57
- Insider filing price
- $69.57
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- UTMD - UTAH MEDICAL PRODUCTS INC - Common Shares is tracked under CUSIP 917488108.
- 113 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 119 to 113 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $140,491,697 to $159,887,229.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 113 institutions filings for Q2 2026.
Security key
917488108
Latest holder period
Q2 2026
13F holders
113
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
UTMD full holder history
UTAH MEDICAL PRODUCTS INC SEC filings
UTAH MEDICAL PRODUCTS INC company facts
UTAH MEDICAL PRODUCTS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 917488108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
UTMD
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 15% | +5.7% | $33,560,410 | +$1,799,511 | 475,158 | +5.7% | BRANDES INVESTMENT PARTNERS, LP | 30 Jun 2026 |
| DIMENSIONAL FUND ADVISORS LP | 6.1% | $11,239,863 | 197,466 | Dimensional Fund Advisors LP | 30 Jun 2025 | |||
| RENAISSANCE TECHNOLOGIES LLC | 5.5% | -17% | $12,417,743 | -$3,870,524 | 175,814 | -24% | Renaissance Technologies LLC | 30 Jun 2026 |
| BlackRock, Inc. | 5.3% | +6.6% | $9,829,260 | +$231,666 | 172,684 | +2.4% | BlackRock, Inc. | 30 Jun 2025 |
| FMR LLC | 2.7% | $4,848,900 | 92,360 | FMR LLC | 31 Dec 2024 |
As of 30 Jun 2026, 113 institutional investors reported holding 2,317,747 shares of UTAH MEDICAL PRODUCTS INC - Common Shares (UTMD). This represents 73% of the company’s total 3,188,980 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
64%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 15% | 475,158 | +5.8% | 0.23% | $32,776,399 |
| BlackRock, Inc. | 6.4% | 203,690 | +8.5% | 0% | $14,050,520 |
| DIMENSIONAL FUND ADVISORS LP | 6.2% | 198,817 | +0.46% | 0% | $13,715,681 |
| RENAISSANCE TECHNOLOGIES LLC | 5.5% | 175,814 | -4.5% | 0.02% | $12,127,650 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 134,535 | -2.9% | 0% | $9,280,224 |
| GEODE CAPITAL MANAGEMENT, LLC | 3.4% | 108,048 | -10% | 0% | $7,454,824 |
| Minerva Advisors LLC | 2.9% | 93,615 | 0% | 4.1% | $6,457,563 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2.7% | 85,231 | -4.4% | 0.02% | $5,879,234 |
| RICE HALL JAMES & ASSOCIATES, LLC | 2.2% | 71,363 | +5.1% | 0.24% | $4,922,620 |
| MORGAN STANLEY | 2.2% | 69,670 | +43% | 0% | $4,805,903 |
| STATE STREET CORP | 2% | 63,937 | -0.72% | 0% | $4,429,595 |
| Quantinno Capital Management LP | 1.4% | 43,074 | +44% | 0% | $2,971,274 |
| UBS Group AG | 1.1% | 34,369 | -6.9% | 0% | $2,370,773 |
| Bank of New York Mellon Corp | 1.1% | 34,263 | +6.8% | 0% | $2,363,453 |
| NORTHERN TRUST CORP | 0.94% | 30,104 | -0.62% | 0% | $2,076,574 |
| Huber Capital Management LLC | 0.91% | 29,009 | -19% | 0.29% | $2,001,041 |
| Cardinal Capital Management | 0.85% | 27,094 | +2.1% | 0.23% | $1,877,213 |
| EVERETT HARRIS & CO /CA/ | 0.75% | 23,933 | -6.4% | 0.02% | $1,650,898 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.69% | 21,938 | +20% | 0% | $1,515,000 |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 0.68% | 21,683 | +1.9% | 0.01% | $1,495,693 |
| SEGALL BRYANT & HAMILL, LLC | 0.68% | 21,547 | 0% | 0.02% | $1,486,312 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.64% | 20,276 | +16% | 0% | $1,398,638 |
| VANGUARD FIDUCIARY TRUST CO | 0.63% | 20,014 | +5% | 0% | $1,380,566 |
| BARD ASSOCIATES INC | 0.58% | 18,455 | +0.51% | 0.28% | $1,278,670 |
| FMR LLC | 0.57% | 18,068 | +0.03% | 0% | $1,246,297 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,317,747 | $159,887,229 | +$3,832,306 | $68.98 | 113 |
| 2026 Q1 | 2,266,199 | $140,491,697 | +$10,514,177 | $61.99 | 119 |
| 2025 Q4 | 2,099,545 | $117,525,511 | -$3,861,909 | $55.96 | 117 |
| 2025 Q3 | 2,166,272 | $136,441,085 | +$654,850 | $62.97 | 115 |
| 2025 Q2 | 2,154,610 | $122,645,130 | -$4,286,491 | $56.92 | 109 |
| 2025 Q1 | 2,232,321 | $125,139,291 | -$4,053,654 | $56.04 | 107 |
| 2024 Q4 | 2,305,146 | $141,733,881 | -$6,984,040 | $61.47 | 112 |
| 2024 Q3 | 2,408,468 | $161,160,273 | +$1,503,694 | $66.91 | 109 |
| 2024 Q2 | 2,402,050 | $160,517,663 | -$6,987,298 | $66.81 | 99 |
| 2024 Q1 | 2,489,842 | $177,079,892 | -$5,994,623 | $71.11 | 99 |
| 2023 Q4 | 2,515,087 | $211,858,896 | -$5,241,769 | $84.22 | 88 |
| 2023 Q3 | 2,572,783 | $221,288,021 | +$1,886,299 | $86.00 | 91 |
| 2023 Q2 | 2,546,722 | $237,462,990 | +$487,123 | $93.20 | 89 |
| 2023 Q1 | 2,542,875 | $241,013,763 | +$8,482,645 | $94.77 | 86 |
| 2022 Q4 | 2,546,245 | $255,980,665 | +$1,190,438 | $100.53 | 81 |
| 2022 Q3 | 2,535,532 | $216,324,656 | -$31,278,340 | $85.31 | 75 |
| 2022 Q2 | 2,559,522 | $219,885,103 | -$450,030 | $85.90 | 74 |
| 2022 Q1 | 2,572,731 | $231,180,696 | -$2,805,351 | $89.86 | 84 |
| 2021 Q4 | 2,603,370 | $260,419,500 | -$912,880 | $100.00 | 78 |
| 2021 Q3 | 2,601,860 | $241,516,691 | +$243,574 | $92.83 | 72 |
| 2021 Q2 | 2,599,575 | $221,087,106 | -$2,811,784 | $85.04 | 68 |
| 2021 Q1 | 2,632,036 | $227,952,680 | +$1,009,922 | $86.60 | 78 |
| 2020 Q4 | 2,620,725 | $220,943,842 | -$2,326,872 | $84.30 | 76 |
| 2020 Q3 | 2,651,007 | $211,813,071 | -$2,768,168 | $79.87 | 83 |
| 2020 Q2 | 2,681,470 | $237,657,730 | +$3,950,332 | $88.62 | 91 |